American Journal of Psychiatry
- Volume 174
- Number 5
- May 2017
Editorials
Introspection
Treatment in Psychiatry
Perspectives in Global Mental Health
Images in Psychiatry
Reviews and Overviews
Publication date: 03 March 2017
Pages430–437Significant controversy surrounds the efficacy of the newer antidepressants for children and adolescents with depression. The controversy largely hinges on meta-analyses of studies that suggest that antidepressants are minimally effective, not effective, ...
https://doi.org/10.1176/appi.ajp.2017.16091059Articles
Publication date: 31 January 2017
Pages438–450Objective: The authors sought to determine the relative morbidity and mortality associated with drugs used to treat depression and to examine specific clinical effects associated with serious outcomes. Method: The National Poison Data System, which receives ...
https://doi.org/10.1176/appi.ajp.2016.16050523Publication date: 20 January 2017
Pages451–458Objective: The purpose of this study was to clarify the magnitude and nature of the relationship between divorce and risk for alcohol use disorder (AUD). Method: In a population-based Swedish sample of married individuals (N=942,366), the authors examined ...
https://doi.org/10.1176/appi.ajp.2016.16050589Publication date: 10 January 2017
Pages459–467Objective: At present there is no established optimal approach for transitioning opioid-dependent adults to extended-release injection naltrexone (XR-naltrexone) while preventing relapse. The authors conducted a trial examining the efficacy of two methods ...
https://doi.org/10.1176/appi.ajp.2016.16050548Publication date: 10 January 2017
Pages468–475Objective: The primary objective of this study was to investigate five putatively functional variants of the norepinephrine transporter (SLC6A2, NET) and serotonin transporter (SLC6A4, SERT) genes and remission in depressed older adults treated with ...
https://doi.org/10.1176/appi.ajp.2016.16050617Publication date: 21 March 2017
Pages476–484Objective: Tardive dyskinesia is a persistent movement disorder induced by dopamine receptor blockers, including antipsychotics. Valbenazine (NBI-98854) is a novel, highly selective vesicular monoamine transporter 2 inhibitor that demonstrated favorable ...
https://doi.org/10.1176/appi.ajp.2017.16091037Letters to the Editor
Book Forum
Official Action
Past Issues
View Issues Archive
Vol. 181 | No. 11
Vol. 181 | No. 10
Vol. 181 | No. 9
